Julie Palmer
Profiles

Julie R Palmer, ScD

Professor, Epidemiology - Boston University School of Public Health

(617) 734-6006
jpalmer@bu.edu
Talbot
View Full Profile at BUMC

Biography

Dr. Palmer is a cancer epidemiologist based at the Slone Epidemiology Center, with research projects spanning cancer early detection, etiology, and survivorship. Her primary focus is on elucidating reasons for the disproportionately high incidence of hormone receptor negative breast cancer in U.S. Black women and on understanding and reducing racial disparities in breast cancer mortality. She is a founding leader of the Black Women’s Health Study (BWHS), a prospective cohort study of 59,000 self-identified Black women who enrolled in 1995 and have been followed by biennial questionnaire since that time. Her breast cancer research within the BWHS includes work on risk prediction models for breast cancer in U.S. Black women, identifying differences in childbearing patterns as a contributing cause to the excess incidence of estrogen receptor negative breast cancer in Black women, and investigating the interrelationships of type 2 diabetes, obesity, and inflammation on breast cancer risk. Her current grants support work on somatic mutations, epigenetics, and gene expressions profiles in breast cancer tumors from African American women, setting the stage for a better understanding of the role of epidemiologic and genetic factors in etiology and prognosis. Dr. Palmer has served on many NIH and external advisory committees, including as Chair of the NIH Cancer, Cardiovascular, and Sleep Epidemiology Study Section, 2015-2017, and Co-Chair of a Working Group for the National Cancer Advisory Board, NCI, 2018-2019. Dr. Palmer was awarded the AACR Distinguished Lectureship on the Science of Cancer Health Disparities in 2017. She has served as a Komen Scholar since 2018 and as a Breast Cancer Research Foundation Investigator since 2023.

Other Positions

  • Karin Grunebaum Cancer Research Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
  • Director, Slone Epidemiology Center - Boston University Chobanian & Avedisian School of Medicine
  • Co-Director, BU-BMC Cancer Center - Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research - Boston University
  • Member, Genome Science Institute - Boston University

Education

  • Harvard University, ScD Field of Study: Epidemiology
  • Boston University, MPH Field of Study: Epidemiology
  • Boston University, BS Field of Study: Nursing
  • Brown University, BA Field of Study: Religious Studies

Websites

Publications

  • Published on 2/5/2026

    Peoples AR, Obón-Santacana M, Kim AE, Kawaguchi ES, Fu Y, Qu C, Moratalla-Navarro F, Morrison J, Lin Y, Arndt V, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, Buchanan DD, Campbell PT, Chan AT, Chang-Claude J, Conti DV, Corley DA, Devall MA, Dimou N, Drew DA, Gruber SB, Gunter MJ, Harlid S, Harrison TA, Hoffmeister M, Hsu L, Huyghe JR, Keku TO, Kundaje A, Lewinger JP, Li L, Lynch BM, Le Marchand L, Martín V, Murphy N, Newton CC, Ogino S, Hardikar S, Ose J, Pai RK, Palmer JR, Papadimitriou N, Pardamean B, Pellatt AJ, Pinchev M, Platz EA, Potter JD, Rennert G, Ruiz-Narvaez EA, Sakoda LC, Schoen RE, Shcherbina A, Stern MC, Su YR, Thomas CE, Tian Y, Tsilidis KK, Um CY, van Duijnhoven FJB, Van Guelpen B, Visvanathan K, Wang J, White E, Wolk A, Woods MO, Wu AH, Ulrich CM, Peters U, Gauderman WJ, Moreno V. Genetic risk factors modulate the association between physical activity and colorectal cancer. BMC Med. 2026 Feb 05; 24(1). PMID: 41645200.

     Read At: PubMed
  • Published on 1/27/2026

    Mitra PR, Bertrand KA, Pfeiffer RM, Palmer JR, Ramireddy S, Hyer M, Fan S, Strohsnitter WC, Aagaard KM, Huo D, Titus L, Troisi R, Gierach GL. Prenatal diethylstilbestrol exposure and risk of benign breast disease: The National Cancer Institute Diethylstilbestrol Follow-up Study. Int J Cancer. 2026 Jun 15; 158(12):3101-3111. PMID: 41590827.

     Read At: PubMed
  • Published on 12/1/2025

    O'Brien KM, Keil AP, Taylor JA, Weinberg CR, Polley EC, Yadav S, Boddicker NJ, Hu C, Ambrosone CB, Anton-Culver H, Auer PL, Bodelon C, Brantley K, Burnside ES, Chen F, Domchek SM, Eliassen AH, Haiman CA, Hodge JM, Kraft P, Lacey JV, Lindstroem S, Martinez ME, Nathanson KL, Neuhausen SL, Olson JE, Palmer JR, Patel AV, Penney KL, Ruddy KJ, Scott CG, Teras LR, Trentham-Dietz A, Vachon CM, Weitzel JN, Yao S, Zirpoli G, Couch FJ, Sandler DP. Pathogenic Variants, Family History, and Cumulative Risk of Breast Cancer in US Women. JAMA Oncol. 2025 Dec 01; 11(12):1458-1469. PMID: 41066089.

     Read At: PubMed
  • Published on 11/25/2025

    Xu NN, Barnard ME, Holder EX, Rosenberg L, Ko N, Palmer JR. Perceived racial discrimination in health care in relation to late stage at breast cancer diagnosis. Breast Cancer Res. 2025 Nov 25; 27(1):208. PMID: 41291827.

     Read At: PubMed
  • Published on 10/30/2025

    Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, Caleca L, Ahearn TU, Andrulis IL, Antoniou AC, Beckmann MW, Behrens S, Bermisheva M, Bogdanova NV, Bolla MK, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Cessna MH, Chang-Claude J, Czene K, Dennis J, Devilee P, Dörk T, Dunning AM, Eriksson M, Evans DG, Fasching PA, Figueroa JD, Gabrielson M, Gago-Dominguez M, González-Neira A, Guénel P, Hadjisavvas A, Hahnen E, Hamann U, Hillemanns P, Hollestelle A, Hooning MJ, Hoppe R, Howell A, Jakubowska A, Kristensen VN, Lubinski J, Lush M, Manoukian S, Mavroudis D, Milne RL, Mulligan AM, Newman WG, Obi N, Panayiotidis MI, Pita G, Rashid MU, Rhenius V, Saloustros E, Sawyer EJ, Schmutzler RK, Shah M, Southey MC, Spurdle AB, Tomlinson I, Truong T, Wang Q, Wendt C, Auer PL, Boddicker NJ, Bodelon C, Burnside ES, Chen F, Couch FJ, Domchek SM, Eliassen HA, Haiman C, Hodge JM, Hu C, Huang H, Lindstrom S, Martinez ME, Nathanson KL, Neuhausen SL, O'Brien KM, Olson JE, Palmer JR, Patel AV, Ruddy KJ, Sandler DP, Teras LR, Weinberg CR, Weitzel JN, Winham SJ, Yadav S, Yao S, Zirpoli G, Janatova M, Kleibl Z, Kleiblova P, Soukupova J, Zhao Q, Devereux L, James PA, Campbell IG, Nguyen-Dumont T, Dowty JG, Andrieu N, Lesueur F, Stoppa-Lyonnet D, Hoya M, Radice P, Sørensen CS, Peterlongo P. Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer. Breast. 2026 Feb; 85:104619. PMID: 41223770.

     Read At: PubMed
  • Published on 10/30/2025

    Jiang SJ, Thomas M, Rosenthal EA, Phipps AI, Sakoda LC, van Duijnhoven FJB, Pellatt AJ, Avery CL, Berndt SI, Bishop DT, Castellví-Bel S, Chan AT, Grant RC, Gignoux C, Gsur A, Gunter MJ, Haiman CA, Hoffmeister M, Jarvik GP, Jenkins MA, Keku TO, Küry S, Lee JK, Marchand LL, Moreno V, Newcomb PA, Newton CC, Ogino S, Palmer JR, Pearlman R, Qu C, Schoen RE, Um CY, Van Guelpen B, Visvanathan K, Vymetalkova V, White E, Woods MO, Platz EA, Brenner H, Corley DA, Vogelaar IL, Hsu L, Peters U. Multiple polygenic score approach in colorectal cancer risk prediction. Sci Rep. 2025 Oct 30; 15(1):38006. PMID: 41168411.

     Read At: PubMed
  • Published on 10/23/2025

    Wesselink AK, Willis MD, Lovett SM, Sheng C, Kuohung W, Hicks J, Peters JL, Sheehy S, Palmer JR, Wise LA, Cozier Y. Neighborhood disadvantage and fecundability in a cohort of US Black women. Environ Epidemiol. 2025 Dec; 9(6):e428. PMID: 41140319.

     Read At: PubMed
  • Published on 10/14/2025

    Holder EX, Szalat R, Palmer JR, Bertrand KA. Neighborhood disadvantage and multiple myeloma incidence in the Black Women's Health Study. Int J Epidemiol. 2025 Oct 14; 54(6). PMID: 41206638.

     Read At: PubMed
  • Published on 9/2/2025

    Nair NM, Mendicino L, Fiorica PN, Omilian AR, Khoury T, Bshara W, Bandera EV, Hong CC, Abdou Y, Freudenheim JL, Hennis AJM, O'Brien KM, Zirpoli GR, Butler EN, Obafunwa JO, Weinberg CR, Huo D, Li B, Guo X, Palmer JR, Haiman CA, Zheng W, Yao S, Ambrosone CB. The African-Specific Variant in the Duffy Antigen Receptor for Chemokines Gene, CD8+ T-Cell Density, and Aggressive Breast Cancer Subtypes in Black Women. Cancer Epidemiol Biomarkers Prev. 2025 Sep 02; 34(9):1509-1515. PMID: 40627176.

     Read At: PubMed
  • Published on 9/2/2025

    Peoples AR, Obón-Santacana M, Kim AE, Kawaguchi ES, Fu Y, Qu C, Moratalla-Navarro F, Morrison J, Lin Y, Arndt V, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, Buchanan DD, Campbell PT, Chan AT, Chang-Claude J, Conti DV, Corley DA, Devall MA, Dimou N, Drew DA, Gruber SB, Gunter MJ, Harlid S, Harrison TA, Hoffmeister M, Hsu L, Huyghe JR, Keku TO, Kundaje A, Lewinger JP, Li L, Lynch BM, Marchand LL, Martín V, Murphy N, Newton CC, Ogino S, Hardikar S, Ose J, Pai RK, Palmer JR, Papadimitriou N, Pardamean B, Pellatt AJ, Pinchev M, Platz EA, Potter JD, Rennert G, Ruiz-Narvaez EA, Sakoda LC, Schoen RE, Shcherbina A, Stern MC, Su YR, Thomas CE, Tian Y, Tsilidis KK, Um CY, van Duijnhoven FJB, van Guelpen B, Visvanathan K, Wang J, White E, Wolk A, Woods MO, Wu AH, Ulrich CM, Peters U, Gauderman WJ, Moreno V. Genetic risk factors modulate the association between physical activity and colorectal cancer. Res Sq. 2025 Sep 02. PMID: 40951278.

     Read At: PubMed

View 500 more publications:View Full Profile at BUMC

News & In the Media

View all profiles